David Nicholson

David Nicholson

Directeur/Membre du Conseil chez ACTINIUM PHARMACEUTICALS, INC.

Fortune : 373 $ au 30/09/2026

72 ans
Health Technology
Commercial Services
Finance

Profil

Dr. David C.
Nicholson
is a Chairman at Exscientia AI Ltd., an Operational Partner at Gilde Healthcare Partners, Inc., a Lead Independent Director at Actinium Pharmaceuticals, Inc. and a Non-Executive Chairman at Wild Bioscience Ltd. He is on the Board of Directors at Tarus Therapeutics, Inc., Science Exchange, Inc., Actinium Pharmaceuticals, Inc., Rapalogix Health, Inc. and Volastra Therapeutics, Inc. Dr. Nicholson was previously employed as an Independent Director by Adverum Biotechnologies, Inc., a Non-Executive Chairman by Exscientia Ltd., a Vice Chairman by Transcelerate Biopharma, Inc., an Executive VP, Chief Research & Development Officer by Allergan Ltd. (Ireland), a Senior Vice President by Forest Laboratories, Inc., a Chief Technology Officer & Executive VP by Bayer CropScience AG, a CTO, Head-Research & Development by Bayer Crop Science Solutions LLC, a Vice President-Licensing & Knowledge Management by Merck & Co., Inc., a SVP-Global Project Management & Drug Safety by Schering-Plough Corp.
USA, an Executive Vice President-Research & Development by Organon Biosciences, Inc., and an Executive Vice President-Research & Development by Organon International, Inc. He also served on the board at Cactus Ventures, Inc. and Actinium Pharmaceuticals, Inc. /Old/.
He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Wales.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
02/10/2026 333 ( 0 % ) 373 $ 30/09/2026

Postes actifs de David Nicholson

SociétésPosteDébut
ACTINIUM PHARMACEUTICALS, INC. Directeur/Membre du Conseil 01/01/2008
Directeur/Membre du Conseil 28/06/2018
Private Equity Investor 01/09/2020
Directeur/Membre du Conseil -
Président 03/11/2023
Président 01/10/2020
Directeur/Membre du Conseil 14/05/2020

Anciens postes connus de David Nicholson

SociétésPosteFin
ADVERUM BIOTECHNOLOGIES, INC. Directeur/Membre du Conseil 09/12/2025
EXSCIENTIA PLC Président 12/02/2024
░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Nicholson

Formation de David Nicholson

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

80

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées22

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

Process Industries

Health Technology

Consumer Services

Organon Biosciences, Inc.

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

  1. Bourse
  2. Insiders
  3. David Nicholson
🔇